(MedPage Today) — The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC).
The product won the indication despite a negative recommendation…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116047
Author :
Publish date : 2025-06-12 19:27:00
Copyright for syndicated content belongs to the linked Source.
